# A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

> **NCT00952419** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 474 (actual)

## Conditions studied

- Influenza
- Swine-origin A/H1N1 Influenza

## Interventions

- **BIOLOGICAL:** Monovalent Subvirion A/H1N1 Influenza vaccine
- **BIOLOGICAL:** Monovalent Subvirion A/H1N1 Influenza vaccine
- **BIOLOGICAL:** Normal saline solution (placebo)

## Key facts

- **NCT ID:** NCT00952419
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-06
- **Target enrollment:** 474 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00952419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00952419, "A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00952419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*